PROSTATE CANCER AWARENESS
SEPTEMBER BRINGS PROSTATE CANCER INTO THE SPOTLIGHT. ELIZABETH TRACEY REPORTS
This year’s prostate cancer awareness week brings lots of controversy to the forefront, leaving most men afloat in a sea of choices regarding screening as well as treatment. Alan Partin, director of the Brady Urological Institute at Johns Hopkins, identifies the issues.
PARTIN: I think the most important thing for people to know today about prostate cancer is that it still is an important disease that affects a lot of men in the country. There’s been a lot of controversy about whether you should get tested, how much tests you should get and whether or not you should get treated. It’s a very complex situation. Not every patient is the same. We really have to sit down with the patients and go over all the options and look at all the data before making these complex decisions. :28
Partin says men should talk first with their primary care doctor about whether to undergo PSA testing, and if needed, seek a center where the range of experts involved in prostate cancer treatment and management can be found. At Johns Hopkins, I’m Elizabeth Tracey.